Gallagher Fiduciary Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Buy
37,693
+2,835
+8% +$31.6K 0.01% 274
2026
Q1
$378K Buy
34,858
+12,211
+54% +$105K 0.01% 222
2025
Q4
$138K Buy
22,647
+1,815
+9% +$10.8K ﹤0.01% 322
2025
Q3
$108K Buy
20,832
+453
+2% +$2.6K ﹤0.01% 304
2025
Q2
$121K Buy
20,379
+3,861
+23% +$23.2K ﹤0.01% 314
2025
Q1
$136K Buy
16,518
+1,662
+11% +$13.9K ﹤0.01% 298
2024
Q4
$123K Buy
14,856
+1,731
+13% +$13.9K 0.02% 291
2024
Q3
$100K Buy
13,125
+3,072
+31% +$28.3K 0.02% 270
2024
Q2
$104K Buy
+10,053
New +$110K 0.02% 252

Other funds holding PTEN

Gallagher Fiduciary Advisors's PTEN Position: Q2 2026 in Review

Gallagher Fiduciary Advisors increased its Patterson-UTI (PTEN) stake by 8.1% in Q2 2026, buying an estimated $31.6K and bringing the position to 37,693 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #274.

Gallagher Fiduciary Advisors first reported a position in PTEN in Q2 2024 and has held it in 9 quarters since. The position peaked at $378K in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Gallagher Fiduciary Advisors held 37,693 shares of Patterson-UTI worth $346K as of Q2 2026.
  • Gallagher Fiduciary Advisors bought 2,835 Patterson-UTI shares in Q2 2026, an estimated $31.6K.
  • Patterson-UTI made up 0.01% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #274 holding.
  • Gallagher Fiduciary Advisors first reported a position in Patterson-UTI in Q2 2024 and has held it in 9 quarters since.
  • Gallagher Fiduciary Advisors's Patterson-UTI position peaked at $378K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.